Friends! In this video, I'm going to discuss 2 Growth stocks to Buy with MASSIVE Upside potential.
2 extracted signals · 2 resolved · 0 still active
The Patient Investor17 Jan 2026, 19:41 UTC
AI-generated source summary
The analysis focuses on two stocks, DUOL and GRAB, with a bearish outlook for DUOL based on slowing user growth and a flat PE ratio. The target for DUOL is not explicitly stated, but the bearish trend suggests a move lower. The analyst believes DUOL is undervalued and could see significant upside if its P/E ratio returns to historical norms. For GRAB, the analysis highlights strong revenue growth and improving profitability, leading to a bullish outlook. The stock is considered undervalued with potential for significant upside, as its P/E ratio is expected to normalize and earnings are projected to increase substantially. The analyst's valuation model suggests GRAB could trade at a P/E of 30-40 times earnings, leading to a potential share price of $12 to $15 within five years.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from The Patient Investor
Why I Don't Own Google Stock & When I'm Buying
The CHEAPEST Quality Stock In The Stock Market!
Intuitive Surgical Stock Analysis! Risks & Upside Potential
There Is NO AI BUBBLE! I’m Buying Every Dip
2 Stocks I'm Buying In The Next 2 Weeks
Netflix Stock Is FINALLY A Buy!
The Patient Investor
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.